Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Ontology highlight
ABSTRACT: RATIONALE: Diagnostic procedures, such as visceral lymphatic mapping using isosulfan blue, may help find cancer of the pancreas, colon, stomach, small intestine, or gallbladder and find out how far the disease has spread.
PURPOSE: This clinical trial is studying the side effects and how well visceral lymphatic mapping using isosulfan blue works in patients with cancer of the pancreas, colon, stomach, small intestine, or gallbladder.
DISEASE(S): Colorectal Cancer,Gastric Cancer,Gallbladder Neoplasms,Small Intestine Cancer,Adenocarcinoma Of The Gallbladder,Pancreatic Cancer,Gallbladder Cancer,Pancreatic Neoplasms,Stomach Neoplasms,Intestinal Neoplasms
PROVIDER: 2041196 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA